Peregrine Pharmaceuticals reported $4.15M in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acceleron Pharma XLRN:US $ -70630000 6.97M
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
Amgen AMGN:US $ 2378M 45M
AstraZeneca AZN:LN -4000000 1.45B
Biocryst Pharmaceuticals BCRX:US $ -44584000 15M
Bristol Myers Squibb BMY:US $ 2985M 18M
Celldex Therapeutics CLDX:US $ -17324000 3.88M
Chemocentryx CCXI:US $ -21803000 16.93M
Dicerna Pharmaceuticals DRNA:US $ -20272000 19.97M
Eli Lilly And LLY:US $ 2055.2M 626.8M
Flexion Therapeutics FLXN:US $ -24158000 7.28M
GlaxoSmithKline GSK:LN 2.67B 712M
Immunogen IMGN:US $ -34234000 6.86M
Karyopharm Therapeutics KPTI:US $ -43812000 5.24M
Kindred Biosciences KIN:US -8544000 622K
Macrogenics MGNX:US $ -52987000 12.71M
Mannkind MNKD:US $ -8552000 479K
Merk MRK:US $ 5352M 3083M
Minerva Neurosciences NERV:US $ -7517620 1.45M
Newlink Genetics NLNK:US -7497000 1.17M
Novartis NOVN:VX 3.48B 77M
Novavax NVAX:US $ -307144000 38.68M
Peregrine Pharmaceuticals PPHM:US $ 4.15M 2.78M
Repligen RGEN:US $ 49.69M 3.27M
Xencor XNCR:US $ -41300000 50.39M